Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

SEC Filing · 144

ResMed Inc.

SEC Filing

Filed Sep 8, 2026Accepted Sep 8, 2026, 1:21 PM EDTCIK 943819Accession 0001959173-26-006784
Share

Company context

Resmed (NYSE: RMD, ASX: RMD) creates life-changing health technologies that people love. We’re relentlessly committed to pioneering innovative technology to empower millions of people in 140 countries to live happier, healthier lives. Our AI-powered digital health solutions, cloud-connected devices and intelligent software make home healthcare more personalized, accessible and effective. Ultimately, Resmed envisions a world where every person can achieve their full potential through better sleep and breathing, with care delivered in their own home. Learn more at Resmed.com and follow @Resmed.

Current securities

Recent company filings

  1. 144 filingSep 2, 2026
  2. Other EventsSep 1, 2026
  3. Changes in Registrant's Certifying Accountant · Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · Regulation FD DisclosureAug 17, 2026
  4. 10-K filingAug 13, 2026
  5. SCHEDULE 13G filingAug 7, 2026

Document unavailable

This filing is not currently available in the archive. Read it on SEC EDGAR ↗